Product Information
DEPO-PROVERA 150 MG/ML VIAL is a brand product labeled by Pharmacia & Upjohn Company LLC, priced at $50.9940 per ML under NDC 00009074630. Its NADAC has been published 337 times since Apr 23, 2014.
FDA first approved this application on Oct 29, 1992. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the medroxyprogesterone acetate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
150 mg/mL
Manufacturer
Pharmacia & Upjohn Company LLCNDC
00009074630
Classification
Brand
Dosage Form
INJECTION, SUSPENSION
Route
INTRAMUSCULAR
Effective Date
4/22/2026
Active Ingredients
MEDROXYPROGESTERONE ACETATEApproval Type
New Drug (NDA)
FDA Application
NDA020246FDA Approved
10/29/1992
TE Code
AB
On Market Since
10/29/1992
Pharmacological Classes
Price Statistics
The NADAC for DEPO-PROVERA 150 MG/ML VIAL has been published 337 times since Apr 23, 2014, and over the history we have for it it has declined 56.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $50.9940 per ML |
|---|---|
| All-time high | $205.3456 (Jan 16, 2019) |
| All-time low | $50.5420 (Jan 22, 2025) |
| 52-week high | $50.9940 |
| 52-week low | $50.6817 |
| Median price | $141.1075 |
| Average price | $134.4168 |
| Largest weekly change | -75.4% (Jan 22, 2025) |
| Weeks tracked | 337 |
| Tracking since | Apr 23, 2014 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 63% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Pharmacia & Upjohn Company LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
medroxyprogesterone acetate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Progestin class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DEPO-PROVERA 150 MG/ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for DEPO-PROVERA 150 MG/ML VIAL, manufactured by Pharmacia & Upjohn Company LLC, is $50.9940 per ML (NDC 00009074630), effective Sep 30, 2026.
How has the price of DEPO-PROVERA 150 MG/ML VIAL changed over time?
Over the history we have for it, the NADAC for DEPO-PROVERA 150 MG/ML VIAL has declined 56.9%. It has been tracked across 337 weekly CMS publications since Apr 23, 2014.
What are the highest and lowest recorded NADAC prices for DEPO-PROVERA 150 MG/ML VIAL?
Since Apr 23, 2014, the NADAC for DEPO-PROVERA 150 MG/ML VIAL has ranged from a low of $50.5420 (Jan 22, 2025) to a high of $205.3456 (Jan 16, 2019), with a median of $141.1075 per ML.
Are there cheaper alternatives to DEPO-PROVERA 150 MG/ML VIAL?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, MEDROXYPROGESTERONE 150 MG/ML, is $18.8535 per ML — about 63% below DEPO-PROVERA 150 MG/ML VIAL.
Who manufactures DEPO-PROVERA 150 MG/ML VIAL?
DEPO-PROVERA 150 MG/ML VIAL (NDC 00009074630) is labeled by Pharmacia & Upjohn Company LLC, and CMS classifies it as a brand product.